On Tuesday, June 2, 2026, partner Christina Schwarz will be a panelist on “Biosimilars and Innovator Biologics Year in Review” at ACI’s Biosimilars & Innovator Biologics summit in New York City. The panel will address how landmark policy changes; FDA draft guidance; procedural and substantive changes at PTAB; shifting IP strategies, global market pressures, and other regulatory updates are changing the landscape.
You can learn more about the summit, which will be held at 3 Times Square, here.